Nathan Rice
Stock Analyst at Piper Sandler
(4.34)
# 533
Out of 4,607 analysts
46
Total ratings
60.71%
Success rate
15.51%
Average return
Main Sectors:
Stocks Rated by Nathan Rice
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BY Byline Bancorp | Reiterates: Overweight | $27 → $34 | $25.34 | +34.18% | 7 | Jul 31, 2024 | |
| BFC Bank First | Maintains: Neutral | $84 → $99 | $86.87 | +13.96% | 4 | Jul 18, 2024 | |
| MBIN Merchants Bancorp | Reiterates: Overweight | $59 → $56 | $43.18 | +29.69% | 4 | May 17, 2024 | |
| CVS CVS Health | Maintains: Buy | $85 → $74 | $62.24 | +18.89% | 2 | May 2, 2024 | |
| FMBH First Mid Bancshares | Maintains: Overweight | $39 → $38 | $37.03 | +2.62% | 2 | Apr 29, 2024 | |
| ALGN Align Technology | Maintains: Sell | $197 → $225 | $238.06 | -5.49% | 11 | Feb 2, 2024 | |
| NIC Nicolet Bankshares | Assumes: Neutral | $84 | $90.86 | -7.55% | 1 | Jan 10, 2024 | |
| ELAN Elanco Animal Health | Maintains: Sell | $11 → $9 | $14.44 | -37.67% | 1 | Apr 25, 2023 | |
| IDXX IDEXX Laboratories | Upgrades: Buy | $530 → $435 | $485.97 | -10.49% | 4 | Jul 21, 2022 | |
| CI The Cigna Group | Initiates: Neutral | $233 | $340.71 | -31.61% | 5 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $83 | $72.62 | +14.29% | 4 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $14.91 | +0.60% | 1 | Dec 19, 2019 |
Byline Bancorp
Jul 31, 2024
Reiterates: Overweight
Price Target: $27 → $34
Current: $25.34
Upside: +34.18%
Bank First
Jul 18, 2024
Maintains: Neutral
Price Target: $84 → $99
Current: $86.87
Upside: +13.96%
Merchants Bancorp
May 17, 2024
Reiterates: Overweight
Price Target: $59 → $56
Current: $43.18
Upside: +29.69%
CVS Health
May 2, 2024
Maintains: Buy
Price Target: $85 → $74
Current: $62.24
Upside: +18.89%
First Mid Bancshares
Apr 29, 2024
Maintains: Overweight
Price Target: $39 → $38
Current: $37.03
Upside: +2.62%
Align Technology
Feb 2, 2024
Maintains: Sell
Price Target: $197 → $225
Current: $238.06
Upside: -5.49%
Nicolet Bankshares
Jan 10, 2024
Assumes: Neutral
Price Target: $84
Current: $90.86
Upside: -7.55%
Elanco Animal Health
Apr 25, 2023
Maintains: Sell
Price Target: $11 → $9
Current: $14.44
Upside: -37.67%
IDEXX Laboratories
Jul 21, 2022
Upgrades: Buy
Price Target: $530 → $435
Current: $485.97
Upside: -10.49%
The Cigna Group
Dec 14, 2021
Initiates: Neutral
Price Target: $233
Current: $340.71
Upside: -31.61%
Dec 14, 2021
Initiates: Neutral
Price Target: $83
Current: $72.62
Upside: +14.29%
Dec 19, 2019
Initiates: Overweight
Price Target: $15
Current: $14.91
Upside: +0.60%